New Two-Pronged attack on advanced prostate cancer enters testing

NCT ID NCT07047118

Recruiting now Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study is testing if adding a new daily pill called JSB462 to a targeted radiation therapy (lutetium) works better than the radiation therapy alone for men with advanced prostate cancer that has stopped responding to standard hormone treatments. The goal is to see if this combination can better control the cancer and extend life. Researchers will also closely monitor side effects to find the best dose for future studies.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Cancer And Blood Spclsts of AZ
RECRUITING

Casa Grande, Arizona, 85122, United States

Contact Email: •••••@•••••

Contact
Carolina Urologic Research Center
WITHDRAWN

Myrtle Beach, South Carolina, 29572, United States
City of Hope National Medical
RECRUITING

Duarte, California, 91010, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Highlands Oncology Group
RECRUITING

Fayetteville, Arkansas, 72703, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Indiana University
RECRUITING

Indianapolis, Indiana, 46202, United States

Contact

Contact Email: •••••@•••••
Massachusetts General Hospital
RECRUITING

Boston, Massachusetts, 02114, United States

Contact Email: •••••@•••••

Contact
NYU Laura and Isaac Perlmutter Cancer Center
RECRUITING

New York, New York, 10016, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Novartis Investigative Site
RECRUITING

Darlinghurst, New South Wales, 2010, Australia
Novartis Investigative Site
RECRUITING

Adelaide, South Australia, 5000, Australia
Novartis Investigative Site
RECRUITING

Melbourne, Victoria, 3004, Australia
Novartis Investigative Site
RECRUITING

Innsbruck, Tyrol, 6020, Austria
Novartis Investigative Site
RECRUITING

Linz, 4020, Austria
Novartis Investigative Site
RECRUITING

Vienna, 1090, Austria
Novartis Investigative Site
RECRUITING

Burnaby, British Columbia, V5G 4P3, Canada
Novartis Investigative Site
RECRUITING

Montreal, Quebec, H3T 1E2, Canada
Novartis Investigative Site
RECRUITING

Beijing, 100034, China
Novartis Investigative Site
RECRUITING

Beijing, 100036, China
Novartis Investigative Site
RECRUITING

Olomouc, 779 00, Czechia
Novartis Investigative Site
RECRUITING

Prague, 150 06, Czechia
Novartis Investigative Site
RECRUITING

Brest, 29200, France
Novartis Investigative Site
RECRUITING

Marseille, 13273, France
Novartis Investigative Site
RECRUITING

Tours, 37044, France
Novartis Investigative Site
RECRUITING

Essen, 45147, Germany
Novartis Investigative Site
RECRUITING

Rostock, 18057, Germany
Novartis Investigative Site
RECRUITING

Afula, 1834111, Israel
Novartis Investigative Site
RECRUITING

Beersheba, 8457108, Israel
Novartis Investigative Site
RECRUITING

Haifa, 3109601, Israel
Novartis Investigative Site
RECRUITING

Jerusalem, 9103102, Israel
Novartis Investigative Site
RECRUITING

Petah Tikva, 4941492, Israel
Novartis Investigative Site
RECRUITING

Ramat Gan, 5265601, Israel
Novartis Investigative Site
RECRUITING

Genova, GE, 16132, Italy
Novartis Investigative Site
RECRUITING

Roma, RM, 00128, Italy
Novartis Investigative Site
RECRUITING

Nijmegen, Gerlderland, 6532 SZ, Netherlands
Novartis Investigative Site
RECRUITING

Leeuwarden, Provincie Friesland, 8934 AD, Netherlands
Novartis Investigative Site
RECRUITING

Hoofddorp, 2134 TM, Netherlands
Novartis Investigative Site
RECRUITING

Singapore, 168583, Singapore
Novartis Investigative Site
RECRUITING

Seoul, 03722, South Korea
Novartis Investigative Site
RECRUITING

Seoul, 05505, South Korea
Novartis Investigative Site
RECRUITING

Granada, Andalusia, 18014, Spain
Novartis Investigative Site
RECRUITING

El Palmar, Murcia, 30120, Spain
Novartis Investigative Site
RECRUITING

Barcelona, 08035, Spain
Novartis Investigative Site
RECRUITING

Seville, 41013, Spain
Novartis Investigative Site
RECRUITING

Taipei, 103616, Taiwan
Novartis Investigative Site
RECRUITING

Taoyuan District, 33305, Taiwan
Providence Saint Johns Health Ctr
RECRUITING

Santa Monica, California, 90404, United States

Contact Email: •••••@•••••

Contact
Rocky Mountain Cancer Centers
RECRUITING

Denver, Colorado, 80218, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Texas Oncology Sammons Cancer Center
WITHDRAWN

Dallas, Texas, 78246, United States
Univ of Pittsburgh Cancer Institute
RECRUITING

Pittsburgh, Pennsylvania, 15232, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Urology San Antonio
RECRUITING

San Antonio, Texas, 78229, United States

Contact

Contact Email: •••••@•••••
XCancer Omaha LLC
RECRUITING

Omaha, Nebraska, 68130, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Yale University School Of Medicine
RECRUITING

New Haven, Connecticut, 06520, United States

Contact Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

PROSTATIC CANCER, CASTRATION-RESISTANT